<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-06-29T07:43:36Z</responseDate><request verb="GetRecord" identifier="oai:docta.ucm.es:20.500.14352/94957" metadataPrefix="oai_dc">https://docta.ucm.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:docta.ucm.es:20.500.14352/94957</identifier><datestamp>2025-03-18T14:06:52Z</datestamp><setSpec>com_20.500.14352_14</setSpec><setSpec>col_20.500.14352_15</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Potential blood biomarkers for stroke</dc:title>
   <dc:creator>Laborde, Carlos </dc:creator>
   <dc:creator>Mourino–Alvarez, Laura</dc:creator>
   <dc:creator>Akerstrom, Finn</dc:creator>
   <dc:creator>Padial, Luis </dc:creator>
   <dc:creator>Vivanco, Fernando</dc:creator>
   <dc:creator>Gil Dones, Félix</dc:creator>
   <dc:creator>Barderas, Maria </dc:creator>
   <dc:subject>577.112</dc:subject>
   <dc:subject>616.831-005.8</dc:subject>
   <dc:subject>577.21</dc:subject>
   <dc:subject>Hemorrhagic stroke</dc:subject>
   <dc:subject>Ischemic stroke</dc:subject>
   <dc:subject>Mass spectrometry</dc:subject>
   <dc:subject>Metabolomics</dc:subject>
   <dc:subject>Potential biomarker</dc:subject>
   <dc:subject>Proteomics</dc:subject>
   <dc:subject>Bioquímica (Biología)</dc:subject>
   <dc:subject>Genética</dc:subject>
   <dc:subject>Neurociencias (Biológicas)</dc:subject>
   <dc:subject>2403 Bioquímica</dc:subject>
   <dc:subject>2409 Genética</dc:subject>
   <dc:subject>2490 Neurociencias</dc:subject>
   <dc:description>Stroke is one of the most common causes of death worldwide and a major cause of acquired disability in adults. Despite advances in research during the last decade, prevention and treatment strategies still suffer from significant limitations, and therefore new theoretical and technical approaches are required. Technological advances in the proteomic and metabolomic areas, during recent years, have permitted a more effective search for novel biomarkers and therapeutic targets that may allow for effective risk stratification and early diagnosis with subsequent rapid treatment. This review provides a comprehensive overview of the latest candidate proteins and metabolites proposed as new potential biomarkers in stroke.</dc:description>
   <dc:description>Depto. de Genética, Fisiología y Microbiología</dc:description>
   <dc:description>Fac. de Ciencias Biológicas</dc:description>
   <dc:description>TRUE</dc:description>
   <dc:description>pub</dc:description>
   <dc:date>2024-01-24T08:50:59Z</dc:date>
   <dc:date>2024-01-24T08:50:59Z</dc:date>
   <dc:date>2012</dc:date>
   <dc:type>journal article</dc:type>
   <dc:type>VoR</dc:type>
   <dc:identifier>https://hdl.handle.net/20.500.14352/94957</dc:identifier>
   <dc:identifier>1478-9450</dc:identifier>
   <dc:identifier>10.1586/epr.12.33</dc:identifier>
   <dc:identifier>1744-8387</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>Laborde, Carlos M., et al. «Potential Blood Biomarkers for Stroke». Expert Review of Proteomics, vol. 9, n.o 4, agosto de 2012, pp. 437-49. https://doi.org/10.1586/epr.12.33.</dc:relation>
   <dc:rights>restricted access</dc:rights>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>Taylor &amp; Francis Online</dc:publisher>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>